Papers in Heart Drug
Page 1 · newest first
- Inhibition of the Renin-Angiotensin System and Atrial Fibrillation in Heart FailureHeart Drug · 2005
- Thromboembolic Prophylaxis with Fondaparinux in Major Orthopaedic Surgery: Outcomes and CostsHeart Drug · 2005
- Sufficient Weight Reduction Decreases Cardiovascular Complications in Diabetic Patients with the Metabolic SyndromeHeart Drug · 2005
- Nesiritide Usage in Decompensated Heart Failure: Cost Effectiveness and Clinical EffectivenessHeart Drug · 2005
- ACE Inhibitors for Older Patients with Heart Failure: A Review of Evidence, Practice Patterns and ChallengesHeart Drug · 2005
- Arrhythmogenic Right Ventricular Cardiomyopathy: A Presentation of Thirty Consecutive PatientsHeart Drug · 2005
- Rationale and Design of the OACIS-LIPID Study That Evaluates Early Use of Pravastatin in Acute Myocardial InfarctionHeart Drug · 2005
- Reduction of Soluble E-Selectin after Combined Treatment with Simvastatin and Vitamins C and EHeart Drug · 2005
- Pharmacological Basics of ƒ-Current InhibitionHeart Drug · 2005
- Additional Features of Beta-BlockersHeart Drug · 2005
- Nicorandil – Review of Pharmacological Properties and Clinical ApplicationsHeart Drug · 2005
- Comparison of Ticlopidine and Aspirin versus Clopidogrel and Aspirin after Percutaneous Coronary Interventions in High-Risk PatientsHeart Drug · 2005
- Utility of Intravenous β-Blocker Administration in Patients with Acute Myocardial Infarction Undergoing Primary Percutaneous InterventionHeart Drug · 2005
- Hyperglycemia after Acute Ischemic Stroke: Prediction, Significance and Immediate Control with Insulin-Potassium-Saline-Magnesium InfusionsHeart Drug · 2005
- Safety of Bone Marrow Stem Cell Mobilization Induced by Granulocyte-Colony Stimulating Factor: 30 Days’ Blinded Clinical Results from the Stem Cells in Myocardial Infarction (STEMMI) TrialHeart Drug · 2005
- Potassium Must Be Considered in Congenital Long QT SyndromeHeart Drug · 2005
- Association of Dyslipidemia and Concomitant Risk Factors with In-Hospital Mortality in Acute Coronary Syndrome in SwitzerlandHeart Drug · 2005
- Clinical Pharmacology of If Current InhibitionHeart Drug · 2005
- Clinical Efficacy of IvabradineHeart Drug · 2005
- 2003 European Society of Hypertension-European Society of Cardiology Guidelines for the Management of Arterial HypertensionHeart Drug · 2004
- Variability in Cytochrome P450-Mediated Metabolism of Cardiovascular Drugs: Clinical Implications and Practical Attempts to Avoid Potential ProblemsHeart Drug · 2004
- Prognostic Comparison of the Minute Ventilation/Carbon Dioxide Production Ratio and Slope in Patients with Heart FailureHeart Drug · 2004
- Changes in Peak Respiratory Flow and Quality of Life during Nebivolol TherapyHeart Drug · 2004
- The Efficacy of Colchicine in the Treatment of Recurrent Pericarditis Related to Postcardiac Injury (Postpericardiotomy and Postinfarcted) Syndrome: A Multicenter AnalysisHeart Drug · 2004
- Peripheral Chemoreceptor Contributions to Cardiovascular RegulationHeart Drug · 2004
- Evidence for the Benefits of the Low-Molecular-Weight Heparin Dalteparin in ‘High-Risk’ Patients with Acute Coronary SyndromesHeart Drug · 2004
- Low-Molecular-Weight Heparin in Acute Coronary SyndromesHeart Drug · 2004
- Methods for the Evaluation of Vascular ReconstructionHeart Drug · 2004
- Regulation of Hemostasis by the Sympathetic Nervous System: Any Contribution to Coronary Artery Disease?Heart Drug · 2004
- ACE Inhibitor, Angiotensin II Receptor Antagonist, Monotherapy or Combined Therapy?Heart Drug · 2004
- Integrilin Dose Optimization Using Cone Plate Analyzer – What Have We Learned Thus FarHeart Drug · 2004
- Age-Dependent Therapeutic Effects of Once-Daily Molsidomine Used as an Add-On Treatment in Patients with Stable Angina pectorisHeart Drug · 2004
- Prognostic Value of INR Fluctuations during Anticoagulant Therapy in Patients with Atrial Fibrillation and a High Thromboembolic RiskHeart Drug · 2004
- Effect of Pulmonary Vein Isolation on Quality of Life in Patients with Paroxysmal Atrial FibrillationHeart Drug · 2003
- Validation of a Multicenter Registry Database of Intra-Aortic Balloon Pumping in a Variety of Clinical SettingsHeart Drug · 2003
- Polymorphisms in the Apolipoprotein(a) Gene, Plasma Lp(a) and Cardiovascular RiskHeart Drug · 2003
- Interim Analyses in Clinical TrialsHeart Drug · 2003
- Nuclear Cardiology Core Laboratory: State of the ArtHeart Drug · 2003
- Assessment of Quality of Life in Pharmacological Treatment of Atrial FibrillationHeart Drug · 2003
- Blinded End Point Adjudication in the ‘Danish Multicenter Randomized Study on Fibrinolytic Therapy versus Acute Coronary Angioplasty in Acute Myocardial Infarction’ (DANAMI-2 Trial)Heart Drug · 2003
- New Insights into Molecular Mechanisms of Atrial Fibrillation: Are We Approaching Possible Novel Pharmacological Principles for Treating This Disorder?Heart Drug · 2003
- Intraoperative Stress EchocardiographyHeart Drug · 2003
- Review of Cardiovascular Disease in Women: Awareness, Prevention, and Psychosocial CharacteristicsHeart Drug · 2003
- Right Heart Catheterization: Indications, Technique, Safety, Measurements, and AlternativesHeart Drug · 2003
- Add-On Benefit to Coronary Artery Bypass Grafting of Treatment with Ramipril for Major Cardiac Events and Left Ventricular Remodeling in Intermediate-Risk PatientsHeart Drug · 2003
- Early Drug Therapy and In-Hospital Mortality following Acute Myocardial InfarctionHeart Drug · 2003
- Value of N-Terminal proBNP in the Diagnosis of Left Ventricular Systolic Dysfunction in Primary Care Patients Referred for EchocardiographyHeart Drug · 2003
- Atrial Fibrillation: Rhythm or Rate Control?Heart Drug · 2003
- Statistical Methods in Genomics ResearchHeart Drug · 2003
- Emerging Role of the Urotensin II System in Cardiovascular DiseaseHeart Drug · 2003